Website Search
ID 2186

Alzheimer's disease - clinical testing

Professor Donna Wilcock explains that Alzheimer's disease is diagnosed clinically by a battery of tests that can take a full day to administer.
Alzheimer’s disease is diagnosed clinically, right now, by a battery of memory tests that are administered typically by a neurologist who is running a memory clinic. These memory tests can take a full day, basically, of different types of memory and recall – maybe telling you a story when you first walk into the clinic and then asking you to recall it a couple hours later. All of these tests test very slightly different mechanisms of memory in different parts of the brain. Based on these, there are some patterns you see that really indicate that yes this really is Alzheimer’s [disease], or no it is different, as there are many other different types of dementia.
alzheimer, disease, diagnosis, clinical, clinic, memory, tests, psychometric, dementia, donna, wilcock
Creative Commons License This work by Cold Spring Harbor Laboratory is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License.

Related content:

2187. Alzheimer's disease - imaging test
Professor Donna Wilcock discusses a new biological technique for diagnosing Alzheimer's disease using PET neuroimaging.
2182. Alzheimer's disease therapy - clinical trials
Professor Donna Wilcock discusses the process of going from a mouse model to human trials for testing the amyloid beta immunization for Alzheimer's disease.
2179. Alzheimer's disease neuropathology - stages
Professor Donna Wilcock describes the neuropathology of Alzheimer's disease as it progresses from the hippocampus to other brain areas.
2227. Alzheimer's disease
An overview of Alzheimer's disease-related content on Genes to Cognition Online.
2184. Education fights Alzheimers disease?
Professor Donna Wilcock discusses research that correlates higher education levels with Alzheimer's disease prevention. This finding has not been fully supported.
2175. Alzheimer's disease medications - Aricept
Professor Donna Wilcock explains that Aricept can only provide short-term benefit in treating Alzheimer's disease.
2177. Cholinergic hypothesis of Alzheimer’s disease
Professor Donna Wilcock dscusses the cholinergic hypothesis of Alzheimer's disease, which focuses on cholinergic neurons. The hypothesis has not been supported.
2174. Neuron loss
Professor Donna Wilcock describes how neurofibrillary tangles choke neurons, causing them to die. This is one of three hallmarks of Alzheimer's disease.
2188. Early-onset Alzheimer's disease, 30-65
Professor Donna Wilcock discusses early-onset Alzheimer's disease, which can reach an advanced stage by the age of 50 or 60 years.
2183. Alzheimer's disease statistics - prevalence and age
Professor Donna Wilcock discusses Alzheimer's disease in the light of increasing prevalence as the population ages.
Cold Spring Harbor Laboratory
CSHL HomeAbout CSHLResearchEducationPublic EventsNewsstandPartner With UsGiving